Shop All
Sea Moss for Dermatomyositis
Sea Moss for Dermatomyositis
Dermatomyositis sits at the crossroads of skin, muscle, and lung, driven by a distinctive type I interferon signature and a microvascular attack on the tissues you rely on every day. Here is an honest, deeply mechanistic look at where the minerals and marine compounds in wildcrafted sea moss may offer nutritional support, and the firm line where they cannot replace your rheumatologist, pulmonologist, or cancer screening.
Try Wildcrafted Sea Moss GelIf you live with dermatomyositis, you carry a disease that announces itself on the surface of your body and quietly works underneath it. The violet eyelids, the scaly knuckles, the climbing-the-stairs weakness, the breathlessness that arrives months before the muscle complaints in some people. It is a condition that touches skin, muscle, lung, and sometimes the deeper question of whether a hidden cancer is driving the whole picture. That breadth is exactly why thoughtful, foundational nutrition matters, and exactly why no supplement can ever stand in for specialist medical care.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy, an autoimmune disease in which the immune system attacks the small blood vessels feeding skeletal muscle and skin. Wildcrafted sea moss delivers a broad spectrum of the 92 minerals the body uses, plus the sulfated marine polysaccharide fucoidan, and several of those components engage pathways that genuinely matter in DM biology: the type I interferon loop, complement-mediated vessel injury, oxidative stress in muscle, and the inflammatory burden in the lung. This page walks through what the science suggests, names the limits clearly, and flags the warnings every adult with DM must take seriously, including mandatory malignancy screening.
Before anything else: Dermatomyositis requires management by a rheumatologist, usually alongside a pulmonologist for lung monitoring and a dermatologist for the skin. Adults with new DM need a mandatory malignancy workup. Sea moss is a supplemental whole food, never a substitute for corticosteroids, methotrexate, IVIG, rituximab, JAK inhibitors, lung surveillance, or cancer screening. Please read the safety and screening sections carefully and coordinate everything with your care team.
What Is Dermatomyositis? The Pathophysiology
To understand where a whole-food approach might fit, you first have to appreciate how unusual the underlying biology of dermatomyositis is. Unlike polymyositis, where killer T-cells invade healthy muscle fibers directly, dermatomyositis is fundamentally a disease of small blood vessels and of a specific immune signaling fingerprint.
The Type I Interferon Signature
The molecular hallmark of dermatomyositis is an exuberant type I interferon (IFN-alpha and IFN-beta) signature. In affected skin and muscle, the genes switched on by type I interferon are abnormally and persistently active. Plasmacytoid dendritic cells (pDCs), the most prolific interferon-producing cells in the body, accumulate in the tissue and pour out interferon, which in turn drives the upregulation of interferon-stimulated genes such as MxA, ISG15, and others. This interferon storm is not a side effect; many researchers regard it as a central engine of the disease, helping to explain the perifascicular pattern of muscle injury and the photosensitive, inflammatory rashes. It is also why JAK inhibitors, which block the downstream interferon signaling pathway, have become an important tool for the most refractory cases.
Complement, Microangiopathy, and Perifascicular Atrophy
Dermatomyositis is a complement-mediated, humoral disease. Autoantibodies and the complement cascade assemble the membrane attack complex (C5b-9) on the walls of the small endomysial capillaries that feed the muscle. These capillaries are damaged and dropped out, producing a microangiopathy, a loss of the tiny blood supply at the edges of the muscle fascicles. Because the periphery of each fascicle is farthest from the remaining blood supply, those fibers suffer most. The result is the classic histological signature of dermatomyositis: perifascicular atrophy, a rim of shrunken, struggling muscle fibers at the margins of the fascicles. B-cells and plasmacytoid dendritic cells populate the inflammatory infiltrate, underscoring that this is an antibody- and interferon-driven process rather than a purely T-cell cytotoxic one.
Myositis-Specific Antibodies (MSA): The Modern Map of the Disease
Perhaps the single most important advance in understanding dermatomyositis is the recognition that it is not one disease but a family of related conditions, each defined by a myositis-specific antibody (MSA). Knowing a patient's antibody often predicts their skin pattern, their lung risk, their cancer risk, and their prognosis better than the muscle biopsy alone.
- Anti-MDA5: Associated with clinically amyopathic dermatomyositis (CADM), where the skin and lungs are affected but muscle strength may be near-normal. This antibody carries the highest risk of rapidly progressive interstitial lung disease (ILD) and is often treated aggressively, frequently with JAK inhibitors for the ILD. It is also linked to distinctive cutaneous ulcers and painful palmar papules.
- Anti-TIF1-gamma: Strongly paraneoplastic in adults, meaning it carries a markedly elevated risk of an underlying cancer, so its presence mandates thorough malignancy screening. In children it is one of the antibodies of juvenile dermatomyositis (JDM) and is associated with extensive skin involvement.
- Anti-NXP2: Strongly associated with calcinosis (calcium deposits in skin and muscle), particularly in juvenile dermatomyositis, and also carries paraneoplastic risk in adults.
- Anti-Mi-2: The "classic" dermatomyositis antibody, associated with the textbook heliotrope rash and Gottron's papules, prominent cutaneous disease, and generally a more favorable prognosis with good treatment response.
- Anti-SAE: Often begins with skin disease that progresses to muscle involvement, and is associated with dysphagia (difficulty swallowing) and a meaningful risk of ILD.
The Skin, the Lung, and the Cancer Question
The classic skin signs of dermatomyositis are described in detail in the visual panel below. Interstitial lung disease affects roughly 20 to 50 percent of patients and is a leading cause of morbidity and mortality, especially in the anti-MDA5 and anti-synthetase groups. And in adults, malignancy screening is mandatory: dermatomyositis can be paraneoplastic, a signal of an occult cancer, with the risk concentrated in the first few years around diagnosis and highest in anti-TIF1-gamma and anti-NXP2 patients.
The treatment backbone: Conventional management typically rests on corticosteroids plus a steroid-sparing immunosuppressant such as methotrexate (or azathioprine, mycophenolate). Intravenous immunoglobulin (IVIG) is FDA-approved for dermatomyositis and used for refractory skin and muscle disease. Rituximab depletes the B-cells driving the antibody response. JAK inhibitors, which interrupt the interferon signaling pathway, have become especially valuable for anti-MDA5-associated rapidly progressive ILD. Sea moss has no role in this backbone; it is, at most, a nutritional companion alongside it.
Skin Manifestations: A Visual Description Panel
The cutaneous signs of dermatomyositis are often the first and most recognizable clue. Learning to picture them helps you describe changes accurately to your dermatologist.
Heliotrope Rash
Named for the violet heliotrope flower, this is a dusky lilac-to-violaceous discoloration of the upper eyelids, often with a faint puffy swelling (periorbital edema). In lighter skin it reads as a distinct purplish shadow draped across the eyelids; in deeper skin tones it can be subtle, appearing as a darker, slightly violet or hyperpigmented patch that is easy to miss. It is one of the most specific signs of dermatomyositis.
Gottron's Papules
Raised, flat-topped, pink-to-violet bumps that sit directly over the bony knuckles, the metacarpophalangeal and interphalangeal joints, and sometimes over the elbows, knees, and ankles. Over time they can become scaly and slightly atrophic, with a shiny, parchment-like surface. The pattern is telling: the rash favors the skin over the joints while sparing the skin between them, the reverse of many other rashes.
V-Sign
A confluent, reddish-violet, often photosensitive rash spreading across the front of the neck and the upper chest in a V-shaped distribution, tracing the area exposed by an open collar. It frequently flares with sun exposure, reflecting the photosensitive nature of dermatomyositis skin disease.
Shawl Sign
A similar violaceous, sun-aggravated erythema, this time draped across the upper back, the shoulders, and the back of the neck, like a shawl resting over the shoulders. Like the V-sign, it is photodistributed and tends to worsen with ultraviolet exposure, which is why rigorous sun protection is a cornerstone of skin care in this disease.
Sea Moss Nutrients and Dermatomyositis Biology
With that biology in view, here is a careful, honest look at the specific components of wildcrafted sea moss and the pathways in dermatomyositis they touch. None of these is a treatment. The value, where it exists, is in foundational nutritional support of an inflamed, oxidatively stressed body.
Fucoidan: Interferon Modulation, Complement, and Anti-Fibrotic Support
Fucoidan, the sulfated polysaccharide concentrated in seaweeds, is the most mechanistically interesting compound in sea moss for dermatomyositis, because it engages several of the exact pathways at the heart of the disease.
- NF-kB and type I interferon pathway modulation: In laboratory and animal models, fucoidan dampens NF-kB signaling, a master regulator of inflammatory gene expression, and has shown inhibitory effects on type I interferon production by plasmacytoid dendritic cells. Given that the type I interferon signature is arguably the central engine of dermatomyositis, this is a strikingly relevant property, though it remains preclinical and is no substitute for a JAK inhibitor.
- Complement C3/C5 inhibition: Sulfated polysaccharides like fucoidan have documented complement-inhibitory activity, interfering with the C3 and C5 convertase steps of the cascade. Because dermatomyositis muscle injury is driven by complement assembling the membrane attack complex on capillaries, a complement-modulating compound is mechanistically aligned with the disease, again at a preclinical level only.
- Perifascicular protection through microvascular support: By tempering complement-mediated capillary injury and the surrounding inflammation, fucoidan's mechanisms point, in theory, toward supporting the very microvasculature whose loss produces perifascicular atrophy.
- Anti-fibrotic activity for ILD support: Fucoidan has shown anti-fibrotic effects in pulmonary fibrosis models, attenuating the TGF-beta-driven scarring that defines progressive interstitial lung disease. For a disease where ILD is a leading cause of harm, this is a meaningful direction of research, while remaining far from clinical proof.
- M2 macrophage polarization: Fucoidan can nudge macrophages toward the M2, tissue-repair phenotype and away from the pro-inflammatory M1 state, supporting a more resolution-oriented immune environment.
Selenium: Muscle Antioxidant Defense and the Selenoprotein-Muscle Connection
Selenium has a uniquely direct connection to muscle health, and that connection is worth understanding in any inflammatory myopathy.
- Glutathione peroxidases (GPx1, GPx4, GPx6) in muscle: Inflamed dermatomyositis muscle generates a heavy load of reactive oxygen species. The selenium-dependent glutathione peroxidase enzymes, including GPx1, GPx4, and GPx6, neutralize that oxidative burden, and they literally cannot function without selenium at their active sites. Low selenium status weakens muscle antioxidant defense precisely when the tissue is under attack.
- Selenoprotein N (SEPN1) and the selenium-muscle link: The clearest proof that selenium matters to muscle comes from genetics: mutations in SEPN1, the gene for selenoprotein N, cause a congenital myopathy (SEPN1-related myopathy). This selenoprotein is essential for the structure and oxidative protection of muscle, a vivid reminder that selenium biology is woven directly into muscle integrity.
- Mitochondrial protection: Selenoproteins help shield muscle mitochondria from oxidative damage, supporting the energy production that weakened, inflamed muscle desperately needs.
On dose: Sea moss provides selenium in the organic selenomethionine form found in food, which the body incorporates readily. The goal is healthy baseline status, not megadosing. Selenium has a relatively narrow safe range and excess is harmful, so keep your provider aware of your total selenium intake from all sources.
Omega-3 (EPA/DHA): Muscle Membranes, Resolvins, and Lung Inflammation
The omega-3 fatty acids touch dermatomyositis at the level of muscle, immune resolution, and lung.
- DHA in muscle membrane phospholipids: DHA is incorporated directly into the phospholipid membranes of muscle cells, influencing membrane fluidity and the function of the receptors and channels embedded there. A muscle membrane rich in omega-3s is biochemically different from one dominated by omega-6 arachidonic acid.
- Resolvin D1 and D3: EPA and DHA are the raw material for specialized pro-resolving mediators, including resolvin D1 and resolvin D3, which actively orchestrate the resolution of inflammation rather than simply blunting it. In a disease defined by smoldering, unresolved inflammation, supporting the body's resolution machinery is conceptually attractive.
- ILD anti-inflammatory support: Omega-3s reduce inflammatory signaling in the lung and have been studied as an adjunct in inflammatory and fibrotic lung conditions, a relevant direction given the ILD burden in dermatomyositis.
- EPA/AA ratio and IL-6 suppression: Raising the EPA-to-arachidonic-acid ratio shifts eicosanoid production toward less inflammatory species and is associated with suppression of interleukin-6 (IL-6), a cytokine elevated in active myositis.
An honest caveat: Sea moss contributes the plant omega-3 precursor alpha-linolenic acid (ALA), and the body's conversion of ALA into the more directly active EPA and DHA is limited, often only a few percent. If you are targeting muscle or lung inflammation through omega-3s specifically, a high-EPA/DHA fish or algal oil is a more efficient source. Sea moss is a supportive whole food here, not the most concentrated omega-3 option.
Zinc: Treg Support, MMP Regulation, and Skin Healing
- FOXP3 regulatory T-cells in IIM: Zinc supports the development and stability of FOXP3-expressing regulatory T-cells (Tregs), the immune cells that hold autoimmunity in check. Regulatory T-cell dysfunction is implicated in the idiopathic inflammatory myopathies (IIM), so adequate zinc status supports the immune brakes the body relies on.
- Zinc metalloprotease and MMP suppression: Zinc is the catalytic metal in matrix metalloproteinases (MMPs), enzymes that remodel and can damage tissue when overactive. Zinc status participates in the regulation of MMP activity, relevant to the tissue remodeling seen in inflamed muscle and skin, and zinc-dependent signaling contributes to keeping that remodeling in check.
- Wound healing for skin and calcinosis: Zinc is essential to skin repair and wound healing, which matters for the cutaneous ulcers of anti-MDA5 disease and the difficult skin changes around calcinosis lesions, particularly in juvenile dermatomyositis.
Iodine: The Thyroid-Muscle Axis
- Hypothyroid myopathy as a differential: Thyroid hormone governs muscle metabolism, and hypothyroidism itself can cause a myopathy with weakness and elevated muscle enzymes that can mimic or coexist with inflammatory myositis. Healthy thyroid function, which depends on iodine, supports normal muscle energetics and removes one confounding contributor to weakness.
- The selenoprotein-iodine-thyroid triad: Iodine and selenium work together in thyroid biology: iodine is built into thyroid hormone, while selenium-dependent deiodinase enzymes convert the storage hormone T4 into the active T3. Sea moss supplies both iodine and selenium, the two minerals that anchor this triad. This interdependence is elegant, but it is also why iodine intake must be kept moderate and monitored, especially in anyone with autoimmune thyroid disease.
Iodine caution: Sea moss naturally contains iodine in variable amounts, and autoimmune thyroid disease can coexist with dermatomyositis. Excess iodine can aggravate an autoimmune thyroid. If you have any thyroid condition or take thyroid medication, talk with your provider before adding sea moss, keep your intake moderate and consistent, and consider periodic thyroid monitoring.
Myositis-Specific Antibody Comparison
This table summarizes how the major myositis-specific (and one anti-synthetase) antibodies map to clinical phenotype, lung risk, cancer risk, and prognosis. It is a learning aid, not a substitute for your own antibody panel and your rheumatologist's interpretation.
| Antibody | Clinical phenotype | ILD risk | Cancer risk | Prognosis |
|---|---|---|---|---|
| Anti-MDA5 | Clinically amyopathic DM (CADM), skin ulcers, palmar papules | Very high (rapidly progressive ILD) | Low to moderate | Guarded; driven by ILD severity |
| Anti-TIF1-gamma | Extensive cutaneous DM; juvenile DM | Low | High (strongly paraneoplastic in adults) | Depends on associated malignancy |
| Anti-NXP2 | Calcinosis; juvenile DM; severe weakness | Low | Moderate to high (paraneoplastic in adults) | Variable; calcinosis can be disabling |
| Anti-Mi-2 | Classic heliotrope and Gottron's; prominent skin disease | Low | Low | Favorable; good treatment response |
| Anti-SAE | Skin-first, progressing to muscle; dysphagia | Moderate | Low to moderate | Generally responsive with treatment |
| Anti-Jo-1 (anti-synthetase) | Antisynthetase syndrome: myositis, mechanic's hands, arthritis, Raynaud's | High | Low | Chronic; ILD often dominates course |
Interstitial Lung Disease: The Monitoring Panel
Because ILD drives so much of the risk in dermatomyositis, understanding how it is monitored helps you partner with your pulmonologist. High-resolution CT (HRCT) of the chest is the central imaging tool, and the pattern it reveals carries prognostic weight.
| HRCT pattern | What it looks like | Significance in DM-ILD |
|---|---|---|
| NSIP (nonspecific interstitial pneumonia) | Symmetric, lower-zone ground-glass opacity with fine reticulation; relative subpleural sparing | The most common pattern in DM-ILD; generally more inflammatory and more responsive to immunosuppression |
| OP (organizing pneumonia) | Patchy consolidation, often peripheral or peribronchial, sometimes migratory | Frequently steroid-responsive; can overlap with NSIP in DM, sometimes signaling active, treatable inflammation |
| UIP (usual interstitial pneumonia) | Basal, subpleural honeycombing and traction bronchiectasis with a fibrotic gradient | Less common in DM but more fibrotic and harder to reverse; signals established scarring |
| Rapidly progressive (anti-MDA5) | Rapidly expanding ground-glass and consolidation, often diffuse | A medical emergency associated with anti-MDA5; treated aggressively, often with JAK inhibitors and combination immunosuppression |
Monitoring typically pairs HRCT with pulmonary function tests, especially the forced vital capacity (FVC) and the diffusing capacity for carbon monoxide (DLCO), which together track how much lung volume and gas-exchange capacity are preserved over time. A falling DLCO can be an early warning. This surveillance is a medical process; sea moss plays no part in it, and any breathlessness, cough, or exertional decline should go straight to your care team.
How Sea Moss Components Map to Dermatomyositis Biology
| Component | Relevant mechanism in DM | Honest limit |
|---|---|---|
| Fucoidan | Modulates NF-kB and type I interferon; complement C3/C5 inhibition; anti-fibrotic; M2 macrophage polarization | Preclinical; not a JAK inhibitor or immunosuppressant |
| Selenium (selenomethionine) | Cofactor for muscle glutathione peroxidases; selenoprotein-muscle integrity; mitochondrial protection | Narrow safe range; baseline support, not megadose |
| Omega-3 (ALA precursor) | Muscle membrane DHA; resolvins D1/D3; ILD support; EPA/AA ratio and IL-6 | Low ALA-to-EPA/DHA conversion; fish/algal oil more efficient |
| Zinc | FOXP3 Treg support; MMP regulation; skin and wound healing | Nutritional support, not immune therapy |
| Iodine | Thyroid-muscle axis; selenoprotein-iodine-thyroid triad | Must stay moderate; risky in autoimmune thyroid disease |
Malignancy Screening: A Warning Every Adult With DM Must Read
This is one of the most important sections on this page. In adults, dermatomyositis can be paraneoplastic, meaning it can be the visible signal of an underlying, sometimes occult, cancer. The risk is concentrated in the first few years around diagnosis and is highest in patients with anti-TIF1-gamma or anti-NXP2 antibodies. For this reason, age- and risk-appropriate malignancy screening is a mandatory, standard part of adult dermatomyositis care, often including imaging, gynecologic and other examinations, and laboratory workup directed by your physician.
No food or natural product treats, prevents, or screens for cancer. Do not let any supplement, including sea moss, delay or substitute for the malignancy workup your rheumatologist recommends. Report new symptoms such as unexplained weight loss, persistent pain, or new lumps promptly.
Medical Care Comes First: What Dermatomyositis Actually Requires
Dermatomyositis requires ongoing management by a rheumatologist, typically with a pulmonologist for lung surveillance and a dermatologist for skin care. Medically indicated treatments may include corticosteroids, steroid-sparing immunosuppressants such as methotrexate, azathioprine, or mycophenolate, intravenous immunoglobulin (IVIG) for refractory disease, rituximab to deplete B-cells, and JAK inhibitors particularly for anti-MDA5-associated rapidly progressive ILD. Care also includes diligent sun protection for the photosensitive skin disease, dysphagia precautions where relevant, and the mandatory malignancy screening described above. Sea moss is supplemental nutritional support only and replaces none of this.
Fucoidan and blood thinners: Fucoidan has mild antiplatelet activity. If you take anticoagulants or have a bleeding disorder, check with your doctor first.
Methotrexate and folate: If you take methotrexate, your folate is managed deliberately by your physician. Do not change your folate intake or add high-folate supplements without that conversation.
Support Your Body, the Whole-Food Way
92 whole-food minerals plus fucoidan. Wildcrafted, never pool-grown. No fillers, no nonsense. Free shipping on orders $65 and up.
Try Wildcrafted Sea Moss GelA Simple Daily Approach
If you and your care team decide sea moss is a reasonable addition to your routine, consistency matters far more than quantity.
Daily gel
One to two tablespoons of wildcrafted sea moss gel per day, blended into a smoothie, stirred into warm (not boiling) water, or taken straight.
Pair with sun protection
The skin disease of DM is photosensitive. Whatever you do nutritionally, rigorous daily sun protection remains foundational for the rash.
Build slowly and consistently
Mineral status and any gut-microbiome benefits build over weeks of steady daily use, not from occasional servings. Start low.
Keep your team informed
Tell your rheumatologist, pulmonologist, and dermatologist what you take, especially given the iodine, selenium, and fucoidan considerations.
Frequently Asked Questions
Can sea moss treat or cure dermatomyositis?
No. Dermatomyositis is a serious autoimmune disease that requires medical treatment such as corticosteroids, methotrexate, IVIG, rituximab, or JAK inhibitors, managed by a rheumatologist. Sea moss is a whole food that supplies minerals and the marine compound fucoidan. Some of its components engage pathways relevant to the disease, such as the type I interferon signature and complement activity, but this is preclinical and mechanistic interest, not a treatment. Sea moss is at most a nutritional companion to your medical care, never a replacement for it.
How might fucoidan relate to the interferon signature in dermatomyositis?
The molecular hallmark of dermatomyositis is an overactive type I interferon (IFN-alpha and IFN-beta) signature, driven in part by plasmacytoid dendritic cells. In laboratory and animal studies, fucoidan can dampen NF-kB signaling and reduce type I interferon production, and it also shows complement-inhibitory activity, which is relevant because complement-mediated capillary injury underlies the muscle damage. These are mechanistically aligned with the disease, but they are preclinical findings. They are not equivalent to a JAK inhibitor, which is the medication class that directly targets interferon signaling in refractory cases.
Is the selenium in sea moss helpful for the muscle involvement?
Selenium has a direct connection to muscle. The selenium-dependent glutathione peroxidase enzymes (GPx1, GPx4) protect muscle from the oxidative stress generated by inflammation, and mutations in the selenoprotein N gene (SEPN1) cause a congenital myopathy, showing how woven selenium is into muscle integrity. Maintaining healthy selenium status supports that antioxidant defense. The aim is baseline adequacy, not megadosing, because selenium has a narrow safe range. Keep your provider aware of your total selenium intake from all sources.
I have anti-MDA5 dermatomyositis. Is sea moss safe for me?
Anti-MDA5 disease carries a high risk of rapidly progressive interstitial lung disease and is treated aggressively under close specialist supervision. Sea moss does not treat ILD, and nothing should delay the urgent immunosuppression and lung monitoring this antibody requires. If your pulmonologist and rheumatologist agree that a whole-food mineral supplement is reasonable alongside your treatment, the same cautions apply as for anyone: watch iodine if you have thyroid disease, and check with your doctor about fucoidan if you take blood thinners. Any new breathlessness or cough is a medical priority, not something to address with a supplement.
Why does my doctor insist on cancer screening, and can sea moss help with that?
In adults, dermatomyositis can be paraneoplastic, meaning it can signal an underlying cancer, with the risk highest in the first few years and in those with anti-TIF1-gamma or anti-NXP2 antibodies. That is why age- and risk-appropriate malignancy screening is a mandatory, standard part of adult DM care. No food or supplement screens for, prevents, or treats cancer. Sea moss has no role here, and it should never delay or replace the workup your physician recommends. Please complete the screening your care team advises.
Can I take sea moss alongside my dermatomyositis medications?
Often yes, but confirm with your doctor first because of a few specific interactions. Fucoidan has mild antiplatelet activity, relevant if you take anticoagulants. Sea moss iodine can interact with thyroid medication and may aggravate autoimmune thyroid disease, which can coexist with DM. And if you take methotrexate, your folate is managed deliberately by your physician, so do not add high-folate supplements without that conversation. Bring the actual product to your appointment so your provider can review the iodine, selenium, and fucoidan content against your medication list.
Related Guides
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Dermatomyositis is a serious systemic autoimmune condition that can involve the lungs and, in adults, can be associated with underlying malignancy. It requires management by a rheumatologist, with pulmonology and dermatology support and mandatory malignancy screening as advised by your physician. Sea moss is supplemental nutritional support only and is not a treatment or cure. Consult your qualified healthcare provider before making any changes to your routine.
